Publications by authors named "Livingstone Gayus Dogara"

Sickle cell disease (SCD) continues to pose physical and psychosocial burdens to patients, caregivers and health workers. Stakeholder engagement in the processes of policy making and implementation is increasingly becoming the cornerstone of best practices in healthcare. To engage stakeholders with a view to assessing the knowledge of SCD; ascertain the challenges associated with accessibility and affordability of healthcare services; improve the quality of care, and thereby effect behavioral change through increasing attendance and follow-up of patients in the clinics.

View Article and Find Full Text PDF

The impact of socio-economic status on the risk of allergy in African children is not clear.This was a cross sectional study including children aged 6-14 years from urban and rural settings in north-central Nigeria. Participants underwent skin prick tests to house dust mite (HDM) and an interview investigating socio-economic status through the Family Affluence Scale (FAS) based on a score of 0-6.

View Article and Find Full Text PDF

Introduction: Lung function abnormalities are common in sickle cell anaemia (SCA) but data from sub-Saharan Africa are limited. We hypothesised that children with SCA from West Africa had worse lung function than their counterparts from Europe.

Methods: This prospective cross-sectional study evaluated spirometry and anthropometry in black African individuals with SCA (haemoglobin phenotype SS) aged 6-18 years from Nigeria and the UK, when clinically stable.

View Article and Find Full Text PDF
Article Synopsis
  • The World Health Organisation classifies myeloproliferative neoplasm (MPN) into two categories: BCR-ABL positive chronic myeloid leukaemia (CML Ph(+)) and Ph(-) MPN, with the JAK2 V617F mutation being common in the latter.
  • The JAK2 mutation occurs in about 50% of cases of primary myelofibrosis, while earlier findings indicated that JAK2 and BCR-ABL mutations usually don't occur together.
  • However, new evidence shows that patients can have both mutations, especially after receiving treatment with tyrosine kinase inhibitors (TKIs), as illustrated by a case of a 60-year-old male exhibiting both types of
View Article and Find Full Text PDF